Health Net
abiraterone (abiraterone)
Drugs for Cancer : Drugs for Cancer
  • Prior Authorization: Metastatic Castrate-Sensitive Prostate Cancer (mCSPC):
    Documented Diagnosis: Yes
    Age Requirement: >= 18
    Duration: 1 plan year
    Reauthorization Required: Yes

    Metastatic Prostate Cancer:
    Documented Diagnosis: Yes
    Age Requirement: >= 18
    Duration: 6 Month(s)
    Reauthorization Required: Yes

  • Limited Access. Must use AcariaHlth Specialty pharmacy. Anti-Cancer: Maximum $200 copayment per State Law.
  • Metastatic Castrate-Sensitive Prostate Cancer (mCSPC):
    Age Requirement: >= 18
    Duration: 1 plan year
    Specialist Required: Yes
    Documented Diagnosis: Yes
    Medical Test Required: No
    Specialist Type(s): 1 of Oncologist;Urologist
    Reauthorization Required: Yes
    Duration of Reauthorization: = 1 plan year

    Metastatic Prostate Cancer:
    Age Requirement: >= 18
    Duration: 6 Month(s)
    Specialist Required: Yes
    Documented Diagnosis: Yes
    Medical Test Required: No
    Specialist Type(s): 1 of Oncologist;Urologist
    Reauthorization Required: Yes
    Duration of Reauthorization: = 1 plan year

  • Step Therapy: Metastatic Castrate-Sensitive Prostate Cancer (mCSPC):
    ST Single Generic